Non-Surgical Approach to Managing Hip Osteoarthritis in Brooklyn
Can Hip Pain from Osteoarthritis Be Addressed Without Surgery?
Non-surgical options for managing hip pain related to osteoarthritis are available through physicians in the licensed Regenexx network.
Pain is one of the most common symptoms associated with hip osteoarthritis, more frequent than joint stiffness or mobility limitations. If a physician has indicated that hip pain is caused by osteoarthritis and that joint replacement is the only path forward, exploring alternative options may be worthwhile.
Hip osteoarthritis develops as the cartilage surfaces within the joint gradually deteriorate. Procedures using Regenexx lab processes utilize interventional orthobiologics that may help support the body’s natural ability to reduce pain and may help improve joint function. These less invasive approaches may offer shorter recovery times and may carry fewer complications when compared to typical surgical interventions.
| Regenexx-SD | Surgery | |
|---|---|---|
| Return to Daily Routine | 2 to 5 days | 6+ weeks |
| Return to Sports | 3 to 6 months | 1 year |
| Recovery | Brace, up to 6 weeks PT | Crutches, brace, extensive, no driving, 3 to 6 months PT |
| Pain Management | Mostly over-the-counter pain medication (days) | Prescription pain medication for weeks (weeks) |
| General Anesthesia | No | Yes |
| Keep Your Hip Joint | Yes | No |
35 West End Avenue
Brooklyn, NY 11235
Request an Appointment
Call to Schedule Schedule OnlineClinic Hours
| Sunday | Closed |
| Monday | 9AM–5PM |
| Tuesday | 9AM–5PM |
| Wednesday | 9AM–5PM |
| Thursday | 9AM–5PM |
| Friday | 9AM–5PM |
| Saturday | Closed |
How Does the Regenexx Approach Work?
The Regenexx approach is a form of interventional orthobiologics that offers an alternative to typical orthopedic surgery. Procedures using Regenexx SD injectate are performed by physicians in the licensed Regenexx network and use advanced image guidance to precisely place a patient’s own bone marrow concentrate, containing cells that may support the body’s natural healing response, into areas of the hip joint where tissue damage has been identified[2-3].
The healing agents in the bone marrow concentrate may help support the repair process by promoting the growth of new tissue. This may aid in stabilizing the hip joint and may help improve function and mobility over time[4].
Am I a candidate?The Regenexx Approach for Hip Pain
Physicians in the licensed Regenexx network take a comprehensive and customized approach to evaluating hip pain. During a patient’s visit, the physician may assess joint function while in motion and use diagnostic ultrasound to view the structures of the hip in real time. This helps identify the underlying factors contributing to pain and limitations in mobility.
Following this thorough evaluation, the physician will develop a customized treatment plan specific to the patient’s condition and needs. Depending on the findings, the plan may include one or more of the following Regenexx injectates:
- Regenexx SD Injectate: Prepared using treatment protocols involving bone marrow concentrate (BMC), which contains the patient’s own mesenchymal signaling cells and other cellular healing agents.
- Regenexx SCP Injectate: A proprietary, lab-processed formulation of platelet-rich plasma (PRP) that contains a higher concentration of growth factors compared to typical PRP preparations.
- Regenexx PL Injectate: A specialized derivative of PRP known as platelet lysate, designed for a faster and more targeted release of growth factors.
These procedures utilize Regenexx lab processes and interventional orthobiologics to may support the body’s natural healing mechanisms, offering a non-surgical alternative for addressing hip pain.
See how Regenexx helped Todd avoid a second hip replacement surgery for hip arthritis.
Note: Like all medical procedures, Regenexx procedures have success and failure rates. Not all patients will experience the same results.
Webinar: Addressing Hip Pain from Osteoarthritis Without Surgery
Join Chris Centeno, M.D., founder of Regenexx, for a free educational webinar exploring how procedures using Regenexx lab processes may offer a non-surgical option for managing hip pain caused by osteoarthritis.
In this webinar, patients will learn:
- How procedures using bone marrow concentrate and platelet-rich plasma (PRP) may compare to typical surgical options and other interventions
- What to expect during and after procedures using Regenexx injectates
- Answers to frequently asked questions about interventional orthobiologics and Regenexx’s proprietary methods
FAQs
Hip osteoarthritis involves the gradual breakdown of cartilage and other joint tissues, which can lead to reduced mobility and joint function. This condition may develop due to factors such as prior injury, inflammatory conditions, genetic predisposition, joint infections, or cumulative wear over time.
While hip arthritis is more commonly diagnosed in individuals in their 60s and 70s, the age of onset can vary based on factors such as physical activity, body weight, and individual joint anatomy.
Not always. In the early stages, hip arthritis may present as stiffness or reduced range of motion rather than pain. As the joint continues to degenerate over time, discomfort or pain often becomes more noticeable.
Yes, MRI imaging can typically reveal degenerative changes in the hip joint. In the video below, Chris Centeno, M.D., highlights three key signs of hip arthritis commonly seen on MRI scans.
At first glance, hip resurfacing may seem less invasive, which often leads people to believe it carries fewer risks. However, that is not always the case. In a conventional hip replacement, both the ball and socket of the joint are removed and replaced with artificial components made from metal, ceramic, or a combination of materials. The stem of the implant is inserted into the marrow space of the femur (thighbone).
In contrast, hip resurfacing preserves more of the natural bone. Rather than removing the ball of the femur, it is reshaped so that a metal covering can be placed over it. While this approach maintains more of the thighbone and is often considered less invasive, studies have shown it may be associated with a higher risk of thigh fractures, larger surgical incisions, pseudotumors, earlier prosthesis failure, and the potential for metal particles to enter the bloodstream due to metal-on-metal implant surfaces.[11-12]
Request an Appointment
References
1. Trouvin AP, Perrot S. Pain in osteoarthritis. Implications for optimal management. Joint Bone Spine. 2018 Jul;85(4):429-434. doi: 10.1016/j.jbspin.2017.08.002. Epub 2017 Sep 6. PMID: 28889010. Sep 6. PMID: 28889010.
2. Centeno CJ. Efficacy and Safety of Bone Marrow Concentrate for Osteoarthritis of the Hip; Treatment Registry Results for 196 Patients. J Stem Cell Res Ther 2014;04(10). doi:10.4172/2157-7633.1000242.
3. Friedlis MF, Centeno CJ. Performing a Better Bone Marrow Aspiration. Phys Med Rehabil Clin N Am. 2016 Nov;27(4):919-939. doi: 10.1016/j.pmr.2016.06.009. PMID: 27788908.
4. Centeno CJ, Kisiday J, Freeman M, Schultz JR. Partial regeneration of the human hip via autologous bone marrow nucleated cell transfer: A case study. Pain Physician. 2006 Jul;9(3):253-6.
5. Lalmohamed A, Vestergaard P, Cooper C, de Boer A, Leufkens HG, van Staa TP, de Vries F. Timing of stroke in patients undergoing total hip replacement and matched controls: a nationwide cohort study. Stroke. 2012 Dec;43(12):3225-9. doi: 10.1161/STROKEAHA.112.668509. Epub 2012 Nov 6. PMID: 23132782.
6. Harding P, Holland AE, Delany C, Hinman RS. Do activity levels increase after total hip and knee arthroplasty? Clin Orthop Relat Res. 2014 May;472(5):1502-11. doi: 10.1007/s11999-013-3427-3. Epub 2013 Dec 19. PMID: 24353051; PMCID: PMC3971219.
7. How long does a hip replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up Evans JT, Evans JP, Walker RW, Blom AW, Whitehouse MR, Sayers A. How long does a hip replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up. Lancet. 2019;393(10172):647-654. doi:10.1016/S0140-6736(18)31665-9
8. Withers TM, Lister S, Sackley C, Clark A, Smith TO. Is there a difference in physical activity levels in patients before and up to one year after unilateral total hip replacement? A systematic review and meta-analysis. Clin Rehabil. 2017;31(5):639-650. doi:10.1177/0269215516673884
9. Sakaguchi M, Tanaka T, Fukushima W, Kubo T, Hirota Y; Idiopathic ONF Multicenter Case-Control Study Group. Impact of oral corticosteroid use for idiopathic osteonecrosis of the femoral head: a nationwide multicenter case-control study in Japan. J Orthop Sci. 2010;15(2):185-191. doi:10.1007/s00776-009-1439-3
10. Ravi B, Escott BG, Wasserstein D, et al. Intraarticular hip injection and early revision surgery following total hip arthroplasty: a retrospective cohort study. Arthritis Rheumatol. 2015;67(1):162-168. doi:10.1002/art.38886
11. Hjorth MH, Mechlenburg I, Soballe K, et al. Higher prevalence of mixed or solid pseudotumors in metal-on-polyethylene total hip arthroplasty compared with metal-on-metal total hip arthroplasty and resurfacing hip arthroplasty. J Arthroplasty, 2018;33:2279–2286. doi:10.1016/j.arth.2018.02.011.
12. Oxblom A, Hedlund H, Nemes S, et al. Patient-reported outcomes in hip resurfacing versus conventional total hip arthroplasty: a register-based matched cohort study of 726 patients. Acta Orthop. 2019;90:318-323. doi:10.1080/17453674.2019.1604343.
